Skip to content

Application of Dexamethasone in Intravenous and Thoracic Parablock to Prevent Shoulder and Back Pain after Thoracoscopic Surgery:A randomized double-blind, prospective, controlled trial

Application of Dexamethasone in Intravenous and Thoracic Parablock to Prevent Shoulder and Back Pain after Thoracoscopic Surgery:A randomized double-blind, prospective, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127265
Enrollment
Unknown
Registered
2026-06-28
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The incidence of ipsilateral shoulder pain (ISP) after thoracoscopic surgery ranges from 21% to 97%, which has become a major clinical issue affecting patients' rehabilitation quality. ISP is defined as ipsilateral shoulder and back pain occurring on the thoracic surgical side within one hour postoperatively.

Interventions

Perineural group:Normal saline 5 mL via intravenous injection
thoracic paravertebral block with 20 mL mixture of 0.5% ropivacaine plus dexamethasone 4 mg
Intravenous group:Normal saline 4 mL + dexamethasone 4 mg(plus 5ml) via intravenous injection
thoracic paravertebral block with 0.5% ropivacaine 20 mL.
Control group:Normal saline 5 mL via intravenous injection

Sponsors

Zigong First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18–75 years; 2. BMI 18.5–28 kg/m^2; 3. ASA physical status I–III; 4. Undergoing an elective unilateral thoracoscopic lobectomy; 5. Estimated operative time 1–3 hours; 6. Written informed consent obtained.

Exclusion criteria

Exclusion criteria: 1.Contraindications of thoracic paravertebral block; 2.Allergy to local anesthetics or dexamethasone; 3.Long-term glucocorticoid use; 4.History of chronic pain; 5.Severe hepatic or renal impairment; 6.Psychiatric disorders or cognitive impairment; 7.Use of NSAIDs or opioids within 24 hours before surgery;

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative ipsilateral shoulder and back pain;

Secondary

MeasureTime frame
Time of the surgery;Complication indicators;Blood glucose;Inflammatory factors (C-reactive protein);Sleep quality assessment;Long-term evaluation;Perioperative anesthetic dosage;Postoperative analgesic consumption;

Countries

China

Contacts

Public ContactQian Liu

Zigong First People's Hospital

liuqianzigong@163.com+86 813 2121126

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026